The healthcare industry is traditionally viewed as a defensive industry to invest in. However, the COVID-19 pandemic has upended this notion. Hospitals have witnessed a fall in patient numbers as movement restriction orders kicked in. Medical tourism, where travellers fly to another country to receive higher-quality medical care, has witnessed dampened demand too. The trends have caused investors to question if healthcare stocks can hold their own through this crisis. One company that has seen its fortunes declining during the pandemic is Raffles Medical Group Ltd (SGX: BSL), or RMG. The group is an integrated, comprehensive healthcare provider that runs a large network of clinics and health screening centres in Singapore and operates medical facilities in 13 other cities across Asia. RMG also owns the flagship Raffles Hospital in Singapore, as well as Raffles Hospital Chongqing in Chongqing, China that started operations in early 2019. Given the pandemic, investors may be wondering whether RMG still qualifies as a healthcare stock to own over the long-term?...